Lyophilized amniotic for the ocular surface.
An aseptically processed, lyophilized amniotic membrane allograft that preserves the native extracellular matrix and endogenous proteins — designed to support healing across a broad range of ocular indications.
An innovative choice in amniotic tissue.
Natural Barrier
Protects the ocular surface from environmental insult during healing.
Physiologic Reservoir
Made of extracellular matrix that supports the regenerative microenvironment.
Simple to Apply
Flexible, opaque graft. No rehydration needed. Direct or BCL technique.
Ambient Storage
Up to 24-month shelf life — no freezer, no thawing, no cold chain.
The power of lyophilization.
Six steps that transform regenerative biology into a stable, shelf-ready, clinician-friendly allograft.
Lyophilization
Sublimation removes water without disrupting biological integrity.
Vacuum-driven freeze-drying produces a dry, stable allograft — eliminating cold-chain dependencies while preserving structure.
Built for the cases that need more than drops.
XcellerEYES has been used by providers across the U.S. for a broad spectrum of ocular surface and post-surgical indications.
A case we should explore?
Talk with a RenVia clinical specialist about how XcellerEYES could fit into your treatment algorithm.
See XcellerEYES in practice.
Hands-on demonstrations, application techniques, and the science behind lyophilization — from leading clinicians.
Common questions.
Ready to elevate ocular surface care?
Tell us about your practice. A RenVia clinical specialist will reach out within one business day to discuss product evaluation, ordering, and clinical support.
- Personalized product evaluation
- Clinical onboarding & training
- Dedicated commercial support
- Streamlined ordering through your existing workflow